- Clone:
- REA131 | J151-21
- Type of antibody:
- Primary antibodies, Recombinant antibodies
- Isotype:
- recombinant human IgG1
- Applications:
- ICFC Glossary
- Select a conjugate:
- Select a size:
Related products for CREB pS133/ATF1 pS63 Antibody, anti-human, REAfinity™
In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.
Cells were incubated with an excess of purified unconjugated CREB pS133/ATF1 pS63 (REA131) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.
Clone REA131 recognizes the serine 133 (S133)–phosphorylated form of the human cAMP responsive element (CRE)–binding transcription factor CREB, a member of a family of cAMP responsive element (CRE)–binding transcription factors that include CREB, CRE modulator (CREM), and activating transcription factor 1 (ATF1). REA131 cross-reacts with the S63-phosphorylated form of human ATF-1. Several different serine-threonine kinases have been shown to promote phosphorylation of CREB at its transcription activating site, S133, including a cAMP-dependent protein kinase A (PKA), protein kinase C (PKC; including PKCε), calmodulin kinases (CaMKs; e.g., CaMK-IV), and pp90 ribosomal S6 kinase (pp90 RSK; also known as RSK2). Once serine 133 of CREB is phosphorylated, CREB interacts with its co-activator protein, CREB-binding protein (CBP), or p300 to initiate transcription of CREB-responsive genes. CREB has been shown to be involved in a variety of cellular processes, including cell proliferation, survival, differentiation, adaptive responses, glucose homeostasis, spermatogenesis, circadian rhythms, and synaptic plasticity associated with memory. CREB plays many different roles in immune function, e.g., through the inhibition of NF-κB activity, the induction of IL-10 and the promotion of FoxP3 expression. CREB promotes activation and proliferation of T and B cells and differentially regulates Tʜ1, Tʜ2, and Tʜ17 responses. CREB is expressed in all somatic cells.
Additional information: Clone REA131 displays negligible binding to Fc receptors.
EWS-ATF1, FUS/ATF-1, TREB36, CREB1
Technical specifications
Recombinant antibodies at Miltenyi Biotec
As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.
The Miltenyi way of generating best-in-class antibodies and antibody conjugates
At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.
Infusing our unique expertise
Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.
Maximizing value for your research
By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:
reduce undesirable binding to Fc gamma receptors,
- eliminate destabilizing amino acid motifs,
- increase specific bonding affinity for stronger, more accurate targeting, and
- optimize fluorochrome conjugation for brighter and clearer signals.
In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.
Better science with quality antibodies
Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).
Overnight cultivated human peripheral blood mononuclear cells (PBMCs), either left unstimulated (left peak) or stimulated with 60 ng/mL phorbol 12-myristate 13-acetate (PMA) and 1 µg/mL ionomycin for 15 minutes, were fixed and permeabilized using Cell Signaling Buffer Set A. Cells were then stained with Anti-CREB pS133/ATF1 pS63 antibodies and analyzed by flow cytometry using the MACSQuant® Analyzer. CD3+ cells were pre-gated for analysis. Cell debris were excluded from the analysis based on scatter signals.
To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.
Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.
- Shaywitz, A. J. et al. (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev. Biochem. 68: 821-861
- Mayr, B. et al. (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2 (8): 599-609
You have previously chosen International as your location.
What do you want to do?